582
against human pulmonary surfactant apoproteins: specificity and application in immunoassay. Biochim Biophys Acta 1985; 836: 201-09. 8. Kuroki Y, Takahashi H, Fukada Y, Mikawa M, Inagawa A, Fujimoto S,
proteinosis: staining for surfactant apoprotein in alveolar proteinosis and in conditions simulating it. Chest 1983; 83: 82-86. 13. Vidone RA, Hoffman L, Hukill PB, Nesbitt KA, McMahon FJ. The diagnosis of pulmonary alveolar proteinosis by sputum examination.
Akino T. Two-site simultaneous immunoassay with monoclonal antibodies for determination of surfactant apoproteins in human amniotic fluid. Pediatr Res 1985; 19: 1017-20. 9. Snyder JM, Kwun JE, O’Brien JA, Rosenfeld CR, Odom MJ. The concentration of the 35-kDa surfactant apoprotein in amniotic fluid from normal and diabetic pregnancies. Pediatr Res 1988; 24: 728-34. 10. Akino T, Shimizu H, Mizumoto M, Kuroki Y, Satoh H, Kataoka K, Hagisawa M, Fujimoto S, Hosoda K, Suzuki H. Simplified monoclonal immunoassay for pulmonary surfactant 35-kDa apoprotein in human amniotic fluid. Clin Chem 1989; 34: 1513. 11. Shimizu H, Hosoda K, Mizumoto M, Kuroki Y, Satoh H, Kataoka K, Hagisawa M, Fujimoto S, Akino T. Improved immunoassay for the determination of surfactant protein A (SP-A) in human amniotic fluid. Tohoku J Exp Med 1989; 157: 269-78. 12. Singh G, Katyal SL, Bedrossian CWM, Rogers RM. Pulmonary alveolar
Dis Chest 1966; 49: 326-32. 14. Costello JF, Moriarty DC, Branthwaite MA, Turner-Warwick M, Corrin B. Diagnosis and management of alveolar proteinosis: the role of electron microscopy. Thorax 1975; 30: 121-32. 15. Smith LJ, Ankin MG, Katzenstein AL, Shapiro BA. Management of pulmonary alveolar proteinosis. Chest 1980; 78: 765-70. 16. Rogers RM, Levin DC, Gray BA, Moseley LW. Physiologic effects of bronchopulmonary lavage in alveolar proteinosis. Am Rev Respir Dis 1978; 118: 255-64. 17. Claypool WD, Rogers RM, Matuschak GM. Update on the clinical diagnosis, management, and pathogenesis of pulmonary alveolar proteinosis (phospholipidosis). Chest 1984; 85: 605-12. 18. Larson PK, Gardin R. Pulmonary alveolar proteinosis: report of six cases, review of the literature and formation of a new therapy. Ann Intern Med 1965; 62: 292-312.
7. Kuroki
Y, Fukuda Y, Takahashi H, Akino T. Monoclonal antibodies
SHORT REPORTS
Cortisol response to corticotropin and survival in septic shock
Corticotropin stimulation tests were used to assess adrenocortical function in 32 patients with septic shock. 13 patients had a poor cortisol response (rise
against human pulmonary surfactant apoproteins: specificity and application in immunoassay. Biochim Biophys Acta 1985; 836: 201-09. 8. Kuroki Y, Takahashi H, Fukada Y, Mikawa M, Inagawa A, Fujimoto S,
proteinosis: staining for surfactant apoprotein in alveolar proteinosis and in conditions simulating it. Chest 1983; 83: 82-86. 13. Vidone RA, Hoffman L, Hukill PB, Nesbitt KA, McMahon FJ. The diagnosis of pulmonary alveolar proteinosis by sputum examination.
Akino T. Two-site simultaneous immunoassay with monoclonal antibodies for determination of surfactant apoproteins in human amniotic fluid. Pediatr Res 1985; 19: 1017-20. 9. Snyder JM, Kwun JE, O’Brien JA, Rosenfeld CR, Odom MJ. The concentration of the 35-kDa surfactant apoprotein in amniotic fluid from normal and diabetic pregnancies. Pediatr Res 1988; 24: 728-34. 10. Akino T, Shimizu H, Mizumoto M, Kuroki Y, Satoh H, Kataoka K, Hagisawa M, Fujimoto S, Hosoda K, Suzuki H. Simplified monoclonal immunoassay for pulmonary surfactant 35-kDa apoprotein in human amniotic fluid. Clin Chem 1989; 34: 1513. 11. Shimizu H, Hosoda K, Mizumoto M, Kuroki Y, Satoh H, Kataoka K, Hagisawa M, Fujimoto S, Akino T. Improved immunoassay for the determination of surfactant protein A (SP-A) in human amniotic fluid. Tohoku J Exp Med 1989; 157: 269-78. 12. Singh G, Katyal SL, Bedrossian CWM, Rogers RM. Pulmonary alveolar
Dis Chest 1966; 49: 326-32. 14. Costello JF, Moriarty DC, Branthwaite MA, Turner-Warwick M, Corrin B. Diagnosis and management of alveolar proteinosis: the role of electron microscopy. Thorax 1975; 30: 121-32. 15. Smith LJ, Ankin MG, Katzenstein AL, Shapiro BA. Management of pulmonary alveolar proteinosis. Chest 1980; 78: 765-70. 16. Rogers RM, Levin DC, Gray BA, Moseley LW. Physiologic effects of bronchopulmonary lavage in alveolar proteinosis. Am Rev Respir Dis 1978; 118: 255-64. 17. Claypool WD, Rogers RM, Matuschak GM. Update on the clinical diagnosis, management, and pathogenesis of pulmonary alveolar proteinosis (phospholipidosis). Chest 1984; 85: 605-12. 18. Larson PK, Gardin R. Pulmonary alveolar proteinosis: report of six cases, review of the literature and formation of a new therapy. Ann Intern Med 1965; 62: 292-312.
7. Kuroki
Y, Fukuda Y, Takahashi H, Akino T. Monoclonal antibodies
SHORT REPORTS
Cortisol response to corticotropin and survival in septic shock
Corticotropin stimulation tests were used to assess adrenocortical function in 32 patients with septic shock. 13 patients had a poor cortisol response (rise
